Stockscreener 앱 받기
0.9859
8.71%
-0.0941
시간 외 거래:
.98
-0.0059
-0.60%
전일 마감가:
$1.08
열려 있는:
$1.07
하루 거래량:
1.65M
Relative Volume:
4.37
시가총액:
$81.51M
수익:
-
순이익/손실:
$-21.65M
주가수익비율:
-2.9687
EPS:
-0.3321
순현금흐름:
$-15.84M
1주 성능:
-28.56%
1개월 성능:
-29.58%
6개월 성능:
-26.97%
1년 성능:
-51.43%
1일 변동 폭
$0.9393
$1.1038
1주일 범위
$0.9393
$1.41
52주 변동 폭
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
명칭
Cardiol Therapeutics Inc
전화
-
주소
-
CRDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
0.9859 | 88.44M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 개시 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-26 | 개시 | ROTH MKM | Buy |
| 2024-04-22 | 개시 | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
(CRDL) Risk-Controlled Trading Report (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics CRDL 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Cardiol Therapeutics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Canadian Pharma Finds Promising Cardiovascular Breakthrough - streetwisereports.com
Is Cardiol Therapeutics a buy? - Cantech Letter
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure - Yahoo Finance
Cardiol Therapeutics Announces US Listing - thedeepdive.ca
Cardiol Therapeutics shares rise 7.48% premarket after positive ARCHER trial results for CardiolRx™. - AInvest
Cardiol falls after mid-stage data for heart disease treatment - MSN
Roth bullish on Cardiol, says trial results enough to attract larger partner - TipRanks
Quantum Biopharma Ltd. shares rise 1.19% after-hours following Cardiol Therapeutics' positive ARCHER trial results. - AInvest
Cardiol data readout positive and not priced in, says H.C. Wainwright - TipRanks
Cardiol Therapeutics’ Cannabidiol Formulation Reduced Inflammation—Phase II Topline Data Ignites the Race to Treat Acute Myocarditis - InvestorNews
Cardiol ARCHER study not statistically significant, says Canaccord - TipRanks
Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Barchart.com
Cardiol falls after mid-stage data for heart disease drug - Seeking Alpha
Cardiol Therapeutics Reports Promising Phase II Trial Results for CardiolRx™ in Acute Myocarditis - TipRanks
Cardiol Therapeutics Announces Topline Results from the Phase II - GuruFocus
(CRDL) Trading Report (CRDL:CA) - news.stocktradersdaily.com
Breakthrough: CardiolRx Trial Reveals New Hope for Acute Myocarditis Patients with Positive Phase II Data - Stock Titan
Cardiol Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsWatchlist for Smart Swing Trading Updated - beatles.ru
Is Cardiol Therapeutics Inc. in Accumulation Phase NowOptimized Watchlist With Daily Adjustments Launched - metal.it
What is the dividend policy of Cardiol Therapeutics Inc. stockGet daily updates on promising stocks - Jammu Links News
Published on: 2025-08-04 07:27:14 - metal.it
What institutional investors are buying Cardiol Therapeutics Inc. stockRobust investment performance - Jammu Links News
How does Cardiol Therapeutics Inc. compare to its industry peersCapitalize on stocks with high profit margins - Jammu Links News
(CRDL) Comprehensive Trading Strategy Report (CRDL:CA) - news.stocktradersdaily.com
What makes Cardiol Therapeutics Inc. stock price move sharplyFree Trend-Following Techniques - Jammu Links News
What are the latest earnings results for Cardiol Therapeutics Inc.Maximize your portfolio’s growth with expert tips - Jammu Links News
How volatile is Cardiol Therapeutics Inc. stock compared to the marketAccess high-yield investment alerts now - Jammu Links News
Should I hold or sell Cardiol Therapeutics Inc. stock in 2025Free Buy/Sell Signal Notifications - Jammu Links News
How strong is Cardiol Therapeutics Inc. company’s balance sheetFree Predictions - Jammu Links News
Does Cardiol Therapeutics Inc. stock perform well during market downturnsMaximize gains with expert analysis - Jammu Links News
What analysts say about Cardiol Therapeutics Inc. stockRapidly expanding wealth - Jammu Links News
Is Cardiol Therapeutics Inc. a growth stock or a value stockUncover the best stocks for explosive growth - Jammu Links News
Is Cardiol Therapeutics Inc. stock overvalued or undervaluedDiscover stocks with superior performance - Jammu Links News
What is Cardiol Therapeutics Inc. company’s growth strategyBuild a winning portfolio with smart picks - Jammu Links News
Why is Cardiol Therapeutics Inc. stock attracting strong analyst attentionUnlock daily stock market insights for success - Jammu Links News
Head to Head Review: Achieve Life Sciences (NASDAQ:ACHV) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World
Published on: 2025-08-03 11:45:58 - Jammu Links News
How to integrate Cardiol Therapeutics Inc. into portfolio analysis toolsSmart Swing Picks with Confirmed Signals - Newser
What technical models suggest about Cardiol Therapeutics Inc.’s comebackFree High Win Rate Trading Opportunities - Newser
Institutional scanner results for Cardiol Therapeutics Inc.Free Breakout Confirmation With Entry Tracker - Newser
Can machine learning forecast Cardiol Therapeutics Inc. recoveryFree Consistent Gain Investment Strategies - Newser
Using flow based indicators on Cardiol Therapeutics Inc.Trading Watchlist with Real Time Filters - Newser
Analyzing drawdowns of Cardiol Therapeutics Inc. with statistical toolsMomentum Trading Guide with Safety Limits - Newser
Visualizing Cardiol Therapeutics Inc. stock with heatmapsReal-Time Setup Summary with ROI Focus - Newser
Real time alert setup for Cardiol Therapeutics Inc. performanceFree Fast Gaining Stock Screener Report - Newser
What are the technical indicators suggesting about Cardiol Therapeutics Inc.AI Powered Tips With High Returns - Jammu Links News
Chart based analysis of Cardiol Therapeutics Inc. trendsStep-by-Step Stock Investment Guide Gains Popularity - metal.it
How to use a screener to detect Cardiol Therapeutics Inc. breakoutsFree Watchlist for Low Risk High Return - Newser
Cardiol Therapeutics Inc (CRDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):